ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Scancell Hldgs (SCLP.LSE)
Scancell Hldgs share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · London Stock Exchange · United Kingdom
£0.890▼ -1.11%
Prices as of Oct 27, 2026 · GBP
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Scancell Hldgs in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Scancell Hldgs
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Scancell Hldgs a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between £0.846 and £0.940; in 9 out of 10, between £0.770 and £1.03. Estimated annual volatility is 15%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- £0.950
- 52-week low
- £0.092
- Gross margin
- 95.0%
- Operating margin
- 0.0%
- Net margin
- 0.0%
- Beta
- 0.69
What this means
ATLAS does not publish a fair value for SCLP.LSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks SCLP.LSE has traded between £0.092 and £0.950. Today it is 6.3% below that high and 867% above its low.
Its beta is 0.69: it tends to move less than the market.
About the company
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.
Want to see everything about Scancell Hldgs?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Scancell Hldgs do?
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.
What is the chance SCLP.LSE goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, SCLP.LSE ends the month between £0.846 and £0.940.
How volatile is SCLP.LSE?
ATLAS estimates annual volatility at 15%. In a typical month, half of the outcomes end between £0.846 and £0.940.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer